• Citer

Feasibility study of EndoTAG-1, a tumor endothelial targeting agent, in combination with paclitaxel followed by FEC as induction therapy in HER2-negative breast cancer

par Ignatiadis, Michail ;Zardavas, Dimitros ;Lemort, Marc ;Wilke, Celine;Vanderbeeken, M.C.;D'Hondt, Veronique ;Azambuja, Evandro ;Gombos, Andrea;Lebrun, Fabienne;Dal Lago, Lissandra ;Bustin, Fanny;Maetens, Marion M. ;Ameye, Lieveke;Veys, Isabelle ;Michiels, Stefan ;Paesmans, Marianne ;Larsimont, Denis ;Sotiriou, Christos ;Nogaret, Jean-Marie ;Piccart-Gebhart, Martine ;Awada, Ahmad
Référence PloS one, 11, 7, e0154009
Publication Publié, 2016-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Feasibility study of EndoTAG-1, a tumor endothelial targeting agent, in combination with paclitaxel followed by FEC as induction therapy in HER2-negative breast cancer
Auteur:	Ignatiadis, Michail; Zardavas, Dimitros; Lemort, Marc; Wilke, Celine; Vanderbeeken, M.C.; D'Hondt, Veronique; Azambuja, Evandro; Gombos, Andrea; Lebrun, Fabienne; Dal Lago, Lissandra; Bustin, Fanny; Maetens, Marion M.; Ameye, Lieveke; Veys, Isabelle; Michiels, Stefan; Paesmans, Marianne; Larsimont, Denis; Sotiriou, Christos; Nogaret, Jean-Marie; Piccart-Gebhart, Martine; Awada, Ahmad
Informations sur la publication:	PloS one, 11, 7, e0154009
Statut de publication:	Publié, 2016-07
Sujet CREF:	Psychologie appliquée
	Sciences bio-médicales et agricoles
	Biologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1932-6203
	info:doi/10.1371/journal.pone.0154009
	info:scp/84979992932